Photo of Peter M. Mauch,  MD

Peter M. Mauch, MD

Brigham And Women's Hospital

Brigham And Women's Hospital
Phone: (617) 632-4116
Fax: (617) 632-4115

Peter M. Mauch, MD

Brigham And Women's Hospital


  • Professor, Radiation Oncology, Harvard Medical School
  • Associate Chair, Radiation Oncology, Brigham And Women's Hospital


Research Abstract


1. Optimizing radiation therapy and chemotherapy in Hodgkin's disease

2. Optimizing radiation therapy for early stage Non-Hodgkin's lymphoma

3. Improving tumor control and engraftment and reducing complications after TBI/TLI for bone marrow transplantation


1. In vitro and in vivo bone marrow stem cell research

2. Toxicity and efficacy of host preparation for bone marrow transplantation

3. Effect of cytotoxic agents and cytokines on hematopoietic stem cells

4. Blood primitive and progenitor cells in hematopoietic stem cell transplantation

5. Factors important for long term hematopoiesis in clinical bone marrow transplantation


Powered by Harvard Catalyst
  • Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Tsien C, Winter JN, Yahalom J, Burns JL, Sundar H. Hodgkin lymphoma, version 2.2015. J Natl Compr Canc Netw 2015; 13:554-86. PubMed
  • Wattson DA, Hunink MG, DiPiro PJ, Das P, Hodgson DC, Mauch PM, Ng AK. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys 2014; 90:344-53. PubMed
  • Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS, Silver B, Fisher DC, Marcus KJ, Mauch PM. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol 2013. PubMed
  • Russo AL, Chen YH, Martin NE, Vinjamoori A, Luthy SK, Freedman A, Michaelson EM, Silver B, Mauch PM, Ng AK. Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure. Int J Radiat Oncol Biol Phys 2013; 86:121-7. PubMed
  • Pashtan I, Mauch PM, Chen YH, Dorfman DM, Silver B, Ng AK. Radiotherapy in the management of localized primary cutaneous B-cell lymphoma. Leuk Lymphoma 2013. PubMed
  • Giardino AA, Shinagare AB, Shinagare SA, Dewar R, Weckstein D, Mauch P, Ramaiya NH, Freedman AS. Primary bone lymphoma involving bilateral tibia. Am J Hematol 2012; 87:924-5. PubMed
  • Halasz LM, Jacene HA, Catalano PJ, Van den Abbeele AD, Lacasce A, Mauch PM, Ng AK. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET. Int J Radiat Oncol Biol Phys 2012; 83:e647-54. PubMed
  • Jiang S, Alberich-Jorda M, Zagozdzon R, Parmar K, Fu Y, Mauch P, Banu N, Makriyannis A, Tenen DG, Avraham S, Groopman JE, Avraham HK. Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. Blood 2011; 117:827-38. PubMed
  • Recklitis CJ, Sanchez Varela V, Ng A, Mauch P, Bober S. Sexual functioning in long-term survivors of Hodgkin's lymphoma. 2010; 19:1229-33. PubMed
  • McCullough L, Ng A, Najita J, Janov A, Henderson T, Mauch P, Diller L. Breastfeeding in survivors of Hodgkin lymphoma treated with chest radiotherapy. Cancer 2010; 116:4866-71. PubMed
  • Galper SL, Yu JB, Mauch PM, Strasser JF, Silver B, Lacasce A, Marcus KJ, Stevenson MA, Chen MH, Ng AK. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 2010. PubMed
  • Chen RC, Chin MS, Ng AK, Feng Y, Neuberg D, Silver B, Pinkus GS, Stevenson MA, Mauch PM. Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up. J Clin Oncol 2009; 28:136-41. PubMed
  • Rodrigues NA,Killion L,Hickey G,Silver B,Martin C,Stevenson MA,Mauch PM,Ng AK. A Prospective Study of Salivary Gland Function in Lymphoma Patients Receiving Head and Neck Irradiation. Int J Radiat Oncol Biol Phys 2009; 75:1079-83. PubMed
  • Chen AB, Punglia RS, Kuntz KM, Mauch PM, Ng AK. Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors. J Clin Oncol 2009; 27:5383-9. PubMed
  • Sher DJ, Mauch PM, Van Den Abbeele A, Lacasce AS, Czerminski J, Ng AK. Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy. Ann Oncol 2009; 20:1848-53. PubMed
  • Ng AK,Mauch PM. Late effects of Hodgkin's disease and its treatment. Cancer J 2009; 15:164-8. PubMed
  • Luthy SK,Ng AK,Silver B,Degnan KO,Fisher DC,Freedman AS,Mauch PM. Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma. Ann Oncol 2008; 19:2043-7. PubMed
  • Ng AK, Li S, Neuberg D, Chi R, Fisher DC, Silver B, Mauch PM. A prospective study of pulmonary function in Hodgkin's lymphoma patients. Ann Oncol 2008; 19:1754-8. PubMed
  • Hoppe RT,Advani RH,Ambinder RF,Bierman PJ,Bloomfield CD,Blum K,Dabaja B,Djulbegovic B,Forero A,Gordon LI,Hernandez-Ilizaliturri FJ,Hudson MM,Kaminski MS,Love G,Maloney DG,Mansur D,Mauch PM,Moore JO,Schilder RJ,Weiss LM,Winter JN,Yahalom J,Zelenetz AD. Hodgkin disease/lymphoma. J Natl Compr Canc Netw 2008; 6:594-622. PubMed
  • Ng AK, Li S, Recklitis C, Diller LR, Neuberg D, Silver B, Mauch PM. Health Practice in Long-Term Survivors of Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 2008; 71:468-76. PubMed
  • Hellman S, Botnick L, Mauch P. Stem-cell biology and cancer therapy: the more things change... J Clin Oncol 2008; 26:821-2. PubMed
  • Brown JR, Feng Y, Gribben JG, Neuberg D, Fisher DC, Mauch P, Nadler LM, Freedman AS. Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission. Biol Blood Marrow Transplant 2007; 13:1057-65. PubMed
  • Tsai HK, Mauch PM. Nodular lymphocyte-predominant hodgkin lymphoma. Semin Radiat Oncol 2007; 17:184-9. PubMed
  • Rohatiner AZ, Nadler L, Davies AJ, Apostolidis J, Neuberg D, Matthews J, Gribben JG, Mauch PM, Lister TA, Freedman AS. Myeloablative Therapy With Autologous Bone Marrow Transplantation for Follicular Lymphoma at the Time of Second or Subsequent Remission: Long-Term Follow-Up. J Clin Oncol 2007; 25:2554-9. PubMed
  • Tsai HK, Li S, Ng AK, Silver B, Stevenson MA, Mauch PM. Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma. Ann Oncol 2007; 18:672-8. PubMed
  • Ng AK, Mauch PM. Role of radiation therapy in localized aggressive lymphoma. J Clin Oncol 2007; 25:757-9. PubMed
  • Ng AK, Mauch PM. The impact of treatment on the risk of second malignancy after Hodgkin's disease. Ann Oncol 2006; 17:1727-9. PubMed
  • Ng AK, Li S, Neuberg D, Fisher DC, McMillan C, Silver B, Marcus KC, Stevenson MA, Mauch PM. Long-term results of a prospective trial of mantle irradiation alone for early-stage Hodgkin's disease. Ann Oncol 2006; 17:1693-7. PubMed
  • Guadagnolo BA, Punglia RS, Kuntz KM, Mauch PM, Ng AK. Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease. J Clin Oncol 2006; 24:4116-22. PubMed
  • Mauch P. Advances in the treatment of Hodgkin lymphoma. Clin Adv Hematol Oncol 2006; 4:652-4, 675. PubMed
  • Das P, Ng AK, Earle CC, Mauch PM, Kuntz KM. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis. Ann Oncol 2006; 17:785-93. PubMed
  • Hoppe RT, Advani RH, Bierman PJ, Bloomfield CD, Buadi F, Djulgegovic B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Kaminski MS, Love G, Maloney DG, Mauch PM, Moore JO, Schilder RJ, Weiss L, Winter JN, Yahalom J, Zelenetz AD,. Hodgkin disease/lymphoma. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2006; 4:210-30. PubMed
  • Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, Mauch PM, Canellos GP, van den Abbeele AD. FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. Leuk Lymphoma 2004; 45:85-92. PubMed